GuideOncology
Performance status: Karnofsky, ECOG and Lansky
Scales that grade the functional capacity of cancer patients: Karnofsky (0–100) and ECOG (0–5) in adults, and Lansky (0–100) in children.
Updated 3 November 2026
When to use it
Before each treatment decision in oncology and haematology: indication for chemotherapy, trial eligibility, prognosis and palliative care.
ECOG (Zubrod / WHO)
• 0: fully active, no restrictions.
• 1: restricted in strenuous physical activity; ambulatory and able to do light or sedentary work.
• 2: ambulatory and capable of self-care but unable to work; up and about more than 50% of waking hours.
• 3: limited self-care; in bed or chair more than 50% of waking hours.
• 4: completely disabled; no self-care, confined to bed or chair.
• 5: dead.
Keep reading in the app
- Karnofsky (KPS)
- Lansky (paediatrics)
- Equivalence and use
Practical tip
Many trials only enrol ECOG 0–1 (or Karnofsky ≥ 70): published results may not apply to patients with poorer performance status.
2 more practical tips in the app.
Reference
- Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55.
- Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949. p. 191-205.
- Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987;60(7):1651-6.
Official source: ECOG-ACRIN: ECOG performance status
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
